Eyebright Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Eyebright Medical Technology
688050 Stock   88.50  1.78  1.97%   
Eyebright Medical financial statements provide useful quarterly and yearly information to potential Eyebright Medical Technology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eyebright Medical financial statements helps investors assess Eyebright Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eyebright Medical's valuation are summarized below:
Gross Profit
491.1 M
Profit Margin
0.2721
Market Capitalization
16.8 B
Enterprise Value Revenue
12.6927
Revenue
1.4 B
We have found sixty-nine available fundamental signals for Eyebright Medical Technology, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Eyebright Medical Technology prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Eyebright Medical Total Revenue

998.74 Million

Check Eyebright Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyebright Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 70.9 M, Interest Expense of 10.3 M or Selling General Administrative of 226.9 M, as well as many indicators such as . Eyebright financial statements analysis is a perfect complement when working with Eyebright Medical Valuation or Volatility modules.
  
This module can also supplement various Eyebright Medical Technical models . Check out the analysis of Eyebright Medical Correlation against competitors.

Eyebright Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 B3.1 B1 B
Slightly volatile
Short and Long Term Debt Total196.6 M187.2 M68.8 M
Slightly volatile
Other Current Liabilities130.4 K137.3 K35.1 M
Slightly volatile
Total Current Liabilities396.7 M377.8 M92 M
Slightly volatile
Total Stockholder Equity1.2 B2.1 B737.4 M
Slightly volatile
Property Plant And Equipment Net1.3 B1.3 B328.7 M
Slightly volatile
Accounts Payable51.5 M49 M8.4 M
Slightly volatile
Cash308 M536.7 M187 M
Slightly volatile
Non Current Assets Total2.1 B2 B572.3 M
Slightly volatile
Non Currrent Assets Other107 M170 M68.3 M
Slightly volatile
Cash And Short Term Investments1 B962.4 M294.6 M
Slightly volatile
Common Stock Shares Outstanding106.7 M189.5 M86.8 M
Slightly volatile
Liabilities And Stockholders Equity2.7 B2.6 B959.9 M
Slightly volatile
Non Current Liabilities Total344.5 M328.1 M83.9 M
Slightly volatile
Inventory190.4 M181.4 M50.8 M
Slightly volatile
Other Current Assets34.6 M36.5 M105 M
Slightly volatile
Other Stockholder Equity845.9 M1.6 B580.5 M
Slightly volatile
Total Liabilities741.1 M705.9 M176 M
Slightly volatile
Total Current Assets718.5 M1 B429.9 M
Slightly volatile
Short Term Debt764.8 K805 K2.7 M
Pretty Stable
Intangible Assets264.8 M252.2 M97 M
Slightly volatile
Common Stock93.5 M121 M78.4 M
Slightly volatile
Short Term Investments19.1 M20.1 M36.4 M
Slightly volatile
Net Receivables113.7 M212.8 M77 M
Slightly volatile
Net Invested Capital1.9 B2.5 B1.1 B
Slightly volatile
Short and Long Term Debt142.4 M135.6 M42.7 M
Slightly volatile
Capital Stock109.9 M105.3 M87.9 M
Slightly volatile
Non Current Liabilities Other1.1 M1.1 M718.7 K
Slightly volatile
Net Working Capital862.1 M645.1 M505.5 M
Slightly volatile
Capital Lease Obligations11.3 M13.9 M5.3 M
Slightly volatile
Property Plant And Equipment Gross883.7 M1.5 B488 M
Slightly volatile
Long Term Debt202.3 M258.5 M155.4 M
Slightly volatile
Good Will139.2 M132.6 M36.4 M
Slightly volatile

Eyebright Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization70.9 M67.5 M23.9 M
Slightly volatile
Interest Expense10.3 M9.8 M2.2 M
Slightly volatile
Selling General Administrative226.9 M216.1 M42.2 M
Slightly volatile
Selling And Marketing Expenses130.4 M124.2 M50.3 M
Slightly volatile
Total Revenue998.7 M951.2 M262.5 M
Slightly volatile
Gross Profit759.1 M722.9 M207.5 M
Slightly volatile
Other Operating Expenses400.1 M381 M147.8 M
Slightly volatile
Research Development98.3 M93.6 M28.6 M
Slightly volatile
EBITDA384 M365.7 M106.9 M
Slightly volatile
Cost Of Revenue239.6 M228.2 M55 M
Slightly volatile
Total Operating Expenses654 M622.9 M157 M
Slightly volatile
Tax Provision25.8 M41.6 M11.9 M
Slightly volatile
Interest Income6.2 M6.4 M5.4 M
Slightly volatile
Net Income From Continuing Ops185.4 M286.1 M108 M
Slightly volatile
Reconciled Depreciation44.3 M76.7 M29.8 M
Slightly volatile
Minority Interest18.8 M17.9 M3.7 M
Slightly volatile

Eyebright Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow234.5 M350 M133.3 M
Slightly volatile
Depreciation80.6 M76.7 M23 M
Slightly volatile
Other Non Cash Items12.8 M19.3 M8.7 M
Slightly volatile
Dividends Paid64.4 M61.4 M14 M
Slightly volatile
Capital Expenditures388.9 M370.3 M126.6 M
Slightly volatile
End Period Cash Flow306.3 M531.8 M185.7 M
Slightly volatile

About Eyebright Medical Financial Statements

Eyebright Medical stakeholders use historical fundamental indicators, such as Eyebright Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eyebright Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eyebright Medical's assets and liabilities are reflected in the revenues and expenses on Eyebright Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eyebright Medical Technology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue951.2 M998.7 M
Cost Of Revenue228.2 M239.6 M

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Eyebright Stock

Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY